Describe recent advances in rectal cancer oncology treatment pathways.
Identify the indications for extended resection for colon, rectal and anal cancer.
Recognize treatment pathway and surveillance options for dysplastic colorectal and anal lesions.
Describe the importance of having multidisciplinary team input for complex cancer cases.
Research discoveries are creating opportunities for greater personalization of treatment. The goal of this CME course is to provide busy clinicians (oncologists, surgeons, radiation oncologists, gastroenterologists, pathologists, radiologists, and interventional radiologists) with clinically relevant, cutting-edge knowledge on best practices. The course will be taught through lectures, clinical case presentations, videos, and a hands-on cadaver lab.
This accredited course is offered by Massachusetts General Hospital. This course is targeted to Surgeons, Nurse Practitioners, Specialty Physicians and Physician Assistants.
Register before March 1, 2024 to receive discounted pricing.
